DossierENTITY

POLB 001

Coverage of POLB 001 in the Nexus archive.

Earliest in view: Jun 14 · 10:00 UTCMost recent: Jun 14 · 10:00 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHJun 14 · 10:00 UTCTHE GUARDIAN WORLD
London startup to trial drug to prevent cancer therapy side-effect ‘cytokine storm’
London-based startup Poolbeg Pharma is trialing POLB 001 at six NHS hospitals to prevent cytokine release syndrome in cancer patients undergoing immunotherapy. The company is also developing a GLP-1 weight loss pill.